The DOWNSIZED channel answers a question about when people stay on the same GLP-1 dose. Their view, not medical advice, so check with a doctor.
Recap by typeshit. Full story at DOWNSIZED.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
Ahead of results, Kalkine looks at how costly late-stage trials for Amgen's monthly obesity shot MariTide weigh on the outlook.
A short post says demand for GLP-1s, psychedelics and testosterone is meeting commercial interests, calling it a big shift.
A beauty take that waves off pricey LA peptide and salmon sperm serums, saying better anti-aging habits are found closer to home.
She says she went from 60 kg to 49 kg without obesity drugs and credits skipping late meals. MoneyToday ties it to a JAMA Network Open review on timed eating.
Employers pick their own contribution toward semaglutide shots or pills. AJMC notes WTW found GLP-1 weight loss coverage fell to 53% of employers, the first drop in three years.
Loading…